… After Ce6 loading, the nanoparticles were mineralized with … Doxorubicin (DOX) is a widely
used chemotherapeutic drug … The in vivo studies show strong chemo-PDT effects of this …

… In fact, the first PEGylated liposomal doxorubicin (DOX) was … However, the robust
applications of nanoemulsions in the … cisplatin (CDDP), where hyaluronic acid (HA) was coated …

… The main obstacle to employing CNTs is their strong … Doxorubicin (DOX) conjugated with
two various ends of … were performed for aminated or PEGylated MWCNTs and HA conjugate …

… of the inorganic nanoparticles and are also capable of drug delivery via a surface polymer.
In addition, polymer composites containing inorganic ceramic nanoparticles have strong …

… the infection severity is inducing a strong acidity change) and in … [83] used the PEGylation
route and the ethylenediamine-… drug delivery platforms for doxorubicin, its release being …

… residue, leading to high doxorubicin toxicity towards cancer cells… with hyaluronic acid and
PEGylated hyaluronic acid mixture. … The prepared micelles were mineralized using calcium …

… loading capacity as well as robust and targeted delivery of a … -fouling functionalization in
comparison to PEGylated MSNs. The … the in situ release of doxorubicin to achieve the tumor-…

… basic research and relatively strong hydrophobicity. In this … amphotericin B, pegylated liposomal
doxorubicin, and liposomal … , namely HA/Zein-DOX NPs, by biomimetic mineralization. In …

… Doxil® and AmBisome® were the first liposomal formulations of Doxorubicin and Amphotericin
B … Albumin-based nanoparticles are usually employed as carriers with passive targeting …

… applications that require strong viscoelastic properties and … efficiency, and circulation time of
doxorubicin in vitro and in vivo [… vitro, and effective formation of mineralized bone in vivo [32]. …